101 related articles for article (PubMed ID: 10867378)
1. [Other forms of immunomodulation in allergic patients].
Cortegano I; Del Pozo V; Rojo M; Cárdaba B; Aceituno E; Gallardo S; Mínguez A; Arrieta I; Palomino P; Lahoz C
Allergol Immunopathol (Madr); 2000; 28(3):102-7. PubMed ID: 10867378
[No Abstract] [Full Text] [Related]
2. Experimental forms of allergen immunotherapy with modified allergens and adjuvants.
Mohapatra SS; San-Juan-Vergara H; Wopfner N; Ferreira F
Clin Allergy Immunol; 2008; 21():393-413. PubMed ID: 18828519
[No Abstract] [Full Text] [Related]
3. [Cytokines and anti-cytokines in allergic diseases].
Fal AM
Pol Merkur Lekarski; 2003 Jun; 14(84):613-6. PubMed ID: 14524284
[TBL] [Abstract][Full Text] [Related]
4. Allergen-related approaches to immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
Maryanoff BE
J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
[No Abstract] [Full Text] [Related]
6. Identification of a serine protease as a major allergen (Per a 10) of Periplaneta americana.
Sudha VT; Arora N; Gaur SN; Pasha S; Singh BP
Allergy; 2008 Jun; 63(6):768-76. PubMed ID: 18445191
[TBL] [Abstract][Full Text] [Related]
7. Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis.
Mo JH; Park SW; Rhee CS; Takabayashi K; Lee SS; Quan SH; Kim IS; Min IY; Raz E; Lee CH
Am J Rhinol; 2006; 20(2):212-8. PubMed ID: 16686392
[TBL] [Abstract][Full Text] [Related]
8. Modifying allergens and using adjuvants for specific immunotherapy.
Larché M; Ferreira F; Mohapatra SS
Clin Allergy Immunol; 2004; 18():641-61. PubMed ID: 15042940
[No Abstract] [Full Text] [Related]
9. Customized antigens for desensitizing allergic patients.
Ferreira F; Wallner M; Thalhamer J
Adv Immunol; 2004; 84():79-129. PubMed ID: 15246251
[No Abstract] [Full Text] [Related]
10. Sensitization of human airways: what is the role of immunoglobulin-E?
Tunon de Lara JM
Clin Exp Allergy; 1998 Jun; 28(6):660-3. PubMed ID: 9677127
[No Abstract] [Full Text] [Related]
11. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
Chang TW; Wu PC; Hsu CL; Hung AF
Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
[TBL] [Abstract][Full Text] [Related]
12. [Levels of interleukin-4, interleukin-5, tryptase and eosinophil cationic protein of nasal lavage fluid in pollen allergic rhinitis].
Rapp J; Kósa L; Halász A; Kereki E; Börzsönyi L
Orv Hetil; 2000 Aug; 141(35):1919-22. PubMed ID: 11019593
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation: the future cure for allergic diseases.
Tsitoura DC; Tassios Y
Ann N Y Acad Sci; 2006 Nov; 1088():100-15. PubMed ID: 17192559
[TBL] [Abstract][Full Text] [Related]
14. Novel 2-(substituted phenyl)benzimidazole derivatives with potent activity against IgE, cytokines, and CD23 for the treatment of allergy and asthma.
Richards ML; Lio SC; Sinha A; Tieu KK; Sircar JC
J Med Chem; 2004 Dec; 47(26):6451-4. PubMed ID: 15588078
[TBL] [Abstract][Full Text] [Related]
15. The anti-allergic activity of the acetate fraction of Schinus terebinthifolius leaves in IgE induced mice paw edema and pleurisy.
Cavalher-Machado SC; Rosas EC; Brito Fde A; Heringe AP; de Oliveira RR; Kaplan MA; Figueiredo MR; Henriques Md
Int Immunopharmacol; 2008 Nov; 8(11):1552-60. PubMed ID: 18672096
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-5: a drug target for allergic diseases.
Sanderson CJ; Urwin D
Curr Opin Investig Drugs; 2000 Dec; 1(4):435-41. PubMed ID: 11249696
[TBL] [Abstract][Full Text] [Related]
17. [Allergic disease treatments: classic and innovative therapeutics].
Têtu L; Didier A
Rev Prat; 2007 Jun; 57(12):1339-48. PubMed ID: 17717947
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
Hessel EM; Chu M; Lizcano JO; Chang B; Herman N; Kell SA; Wills-Karp M; Coffman RL
J Exp Med; 2005 Dec; 202(11):1563-73. PubMed ID: 16314434
[TBL] [Abstract][Full Text] [Related]
19. Tryptase inhibitors in the treatment of pulmonary diseases.
Gangloff AR
Curr Opin Investig Drugs; 2000 Sep; 1(1):79-85. PubMed ID: 11249600
[No Abstract] [Full Text] [Related]
20. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
